Pediatric Blood Cancer

If your child is diagnosed with a blood cancer such as leukemia or lymphoma, you want to turn to a trusted provider for care.

UT Southwestern Harold C. Simmons Comprehensive Cancer Center, in partnership with Children’s Health, located on the same Dallas campus, has an excellent team of pediatric oncologists who treat pediatric leukemias and lymphomas.

Leukemia is the most common childhood cancer. We treat every type of leukemia in children and adolescents, from the most frequently occurring forms of the disease to the most rare. These include:

  • T- and B-precursor acute lymphoblastic leukemias
  • Infant leukemia
  • Transient myeloproliferative disease
  • Acute and chronic myeloid leukemias 
  • Burkitt’s leukemia
  • Rare histologies, including acute blastic plasmacytoid dendritic neoplasms 

Lymphoma is a cancer of the immune system and lymphoid tissues. We treat all forms of pediatric Hodgkin and non-Hodgkin lymphomas. As a group, lymphomas represent the third most common childhood cancer.

Highlights of Our Program

Our large program treats many children, giving us a level of expertise and experience that’s unmatched in the area.

Through our relationship with the Children’s Oncology Group (COG), a National Cancer Institute-supported clinical trials group, we have access to the latest treatments, information, and support from all over the world. In addition, we have access to new agent trials through the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) consortium, and we offer CAR T-cell therapy for eligible children with relapsed or refractory acute lymphoblastic leukemia (ALL).

Our own Naomi Winick, M.D., Professor of Pediatrics, has held several leadership positions with COG and is involved in clinical trials for pediatric leukemia.

Pediatric blood cancer patients treated at UT Southwestern and Children’s Health also have access to:

  • A multidisciplinary team that meets weekly to review each current patient’s status
  • Molecular diagnostics performed at the time of diagnosis to check for treatable genetic abnormalities in the malignant cells
  • Constant assessment of maintenance phase treatments through blood count analysis
  • Multiple therapies for relapsed/recurring disease
  • A clinical trial involving immunotherapy treatment for acute lymphoblastic leukemia – research that is not available anywhere else in Texas or the surrounding states

Request an Appointment

To schedule an appointment with a pediatric blood cancer specialist, request an appointment or call 214-645-8300.